Table 2.

Treatment response of SR aGVHD between the two groups at day 28

Outcomes	MSC group	Control group	P
No. of patients	99	99
OR rate of aGVHD grade
II	35 (97.2%)	34 (91.9%)	0.317
III	33 (80.5%)	30 (68.2%)	0.196
IV	14 (63.6%)	6 (33.3%)	0.057
OR rate of aGVHD involved organs numbers
1	24 (96.0%)	26 (89.7%)	0.375
》 2	58 (78.4%)	44 (62.9%)	0.002
OR rate of aGVHD organs
Skin	64 (87.7%)	50 (79.4%)	0.190
Liver	33 (76.7%)	32 (69.6%)	0.446
Upper GI	9 (100.0%)	9 (90.0%)	0.330
Lower GI	54 (68.4%)	46 (59.7%)	0.262
OR rate of patients’ age
< 18 year	12 (85.7%)	11 (64.7%)	0.183
≥ 18 year	70 (82.4%)	59 (71.9%)	0.109